| scholarly article | Q13442814 |
| P356 | DOI | 10.1359/JBMR.2003.18.11.2060 |
| P953 | full work available at URL | https://academic.oup.com/jbmr/article-pdf/18/11/2060/56470681/5650181118.pdf |
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1359%2Fjbmr.2003.18.11.2060 | ||
| P698 | PubMed publication ID | 14606520 |
| P5875 | ResearchGate publication ID | 9017646 |
| P50 | author | Chafik Ghayor | Q42834864 |
| Jérome Guicheux | Q42834877 | ||
| Gaby Palmer | Q62668405 | ||
| P2093 | author name string | A. Suzuki | |
| J. Lemonnier | |||
| J. Caverzasio | |||
| P2860 | cites work | Murine osteoblastlike cells and the osteogenic cell MC3T3-E1 release a macrophage colony-stimulating activity in culture | Q70362573 |
| The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro | Q72237332 | ||
| Tensile stress induces bone morphogenetic protein 4 in preosteoblastic and fibroblastic cells, which later differentiate into osteoblasts leading to osteogenesis in the mouse calvariae in organ culture | Q73374689 | ||
| Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells | Q73853205 | ||
| Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation | Q74455662 | ||
| Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts | Q77551513 | ||
| Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase | Q77906539 | ||
| Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells | Q77932849 | ||
| The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation | Q24292169 | ||
| Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription | Q24311810 | ||
| Smads bind directly to the Jun family of AP-1 transcription factors | Q24685193 | ||
| Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development | Q28119185 | ||
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling | Q28139205 | ||
| Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development | Q28268881 | ||
| SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase | Q28364720 | ||
| Structure and expression of rat osteosarcoma (ROS 17/2.8) alkaline phosphatase: product of a single copy gene | Q28583797 | ||
| The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase | Q28628494 | ||
| Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
| AP-1 in cell proliferation and survival | Q29615217 | ||
| Organization and regulation of mitogen-activated protein kinase signaling pathways | Q33333640 | ||
| Bone morphogenetic proteins: an update on basic biology and clinical relevance | Q33604511 | ||
| MAP kinase pathways | Q33650641 | ||
| The stress-activated protein kinase pathways | Q33732869 | ||
| The p38/reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells | Q34434997 | ||
| Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts | Q37388231 | ||
| Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-beta superfamily | Q40406239 | ||
| Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix | Q40699220 | ||
| Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. | Q40722201 | ||
| Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. | Q41069920 | ||
| Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts | Q41090627 | ||
| Complementary DNA for human T-cell cyclophilin. | Q41338019 | ||
| In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria | Q41387920 | ||
| Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro | Q41655612 | ||
| Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells | Q42818438 | ||
| Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation | Q42819769 | ||
| Mechanism of the mitogenic effect of fluoride on osteoblast-like cells: evidences for a G protein-dependent tyrosine phosphorylation process. | Q42833404 | ||
| Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2. | Q43832936 | ||
| Stress-activated protein kinase/c-Jun N-terminal kinase (JNK) plays a part in endothelin-1-induced vascular endothelial growth factor synthesis in osteoblasts | Q44192460 | ||
| Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1 | Q68186574 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell differentiation | Q210861 |
| Orthopedics and sports medicine | Q72419165 | ||
| P304 | page(s) | 2060-2068 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Journal of Bone and Mineral Research | Q15750941 |
| P1476 | title | Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation | |
| Activation of p38 Mitogen-Activated Protein Kinase and c-Jun-NH2-Terminal Kinase by BMP-2 and Their Implication in the Stimulation of Osteoblastic Cell Differentiation | |||
| P478 | volume | 18 |
| Q36909540 | A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro |
| Q34527178 | A review of crosstalk between MAPK and Wnt signals and its impact on cartilage regeneration |
| Q28297368 | Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells |
| Q39548366 | Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor |
| Q38686164 | Activation of the Extracellular Signal-Regulated Kinase Signaling Is Critical for Human Umbilical Cord Mesenchymal Stem Cell Osteogenic Differentiation. |
| Q44183241 | Antagonistic and synergistic effects of bone morphogenetic protein 2/7 and all-trans retinoic acid on the osteogenic differentiation of rat bone marrow stromal cells |
| Q53499368 | Apigenin promotes osteogenic differentiation of human mesenchymal stem cells through JNK and p38 MAPK pathways. |
| Q39567867 | Asperosaponin VI, a saponin component from Dipsacus asper wall, induces osteoblast differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway |
| Q39227934 | B2A, a receptor modulator, increases the growth of pluripotent and preosteoblast cells through bone morphogenetic protein receptors |
| Q33917193 | BMP signaling balances murine myeloid potential through SMAD-independent p38MAPK and NOTCH pathways |
| Q37352895 | BMP signaling dynamics in embryonic orofacial tissue |
| Q36731376 | BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype |
| Q98290877 | BMP-2 Signaling and Mechanotransduction Synergize to Drive Osteogenic Differentiation via YAP/TAZ |
| Q50676343 | BMP-2 induction of Dlx3 expression is mediated by p38/Smad5 signaling pathway in osteoblastic MC3T3-E1 cells. |
| Q37140444 | BMP-2 vs. BMP-4 expression and activity in glucocorticoid-arrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization |
| Q24328930 | BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells |
| Q37077401 | BMPR2-pSMAD1/5 signaling pathway regulates RUNX2 expression and impacts the progression of dedifferentiated chondrosarcoma |
| Q37983414 | BMPs are mediators in tissue crosstalk of the regenerating musculoskeletal system |
| Q36287687 | Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems. |
| Q36239423 | Bone Morphogenetic Protein-9 Enhances Osteogenic Differentiation of Human Periodontal Ligament Stem Cells via the JNK Pathway |
| Q38872877 | Bone Morphogenetic Proteins in Vascular Homeostasis and Disease |
| Q37313318 | Bone formation induced by BMP-2 in human osteosarcoma cells |
| Q35087897 | Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype |
| Q42795517 | Bone morphogenetic protein-9 induces PDLSCs osteogenic differentiation through the ERK and p38 signal pathways |
| Q28507461 | Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2 |
| Q90623918 | CB1 enhanced the osteo/dentinogenic differentiation ability of periodontal ligament stem cells via p38 MAPK and JNK in an inflammatory environment |
| Q35230062 | CB2 cannabinoid receptor targets mitogenic Gi protein–cyclin D1 axis in osteoblasts |
| Q46213233 | Cissus quadrangularis extract enhances biomineralization through up-regulation of MAPK-dependent alkaline phosphatase activity in osteoblasts. |
| Q36054631 | Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma |
| Q37416035 | Cordyceps sinensis health supplement enhances recovery from taxol-induced leukopenia |
| Q37277772 | Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development |
| Q43235373 | Differential effects of hypoxia on osteochondrogenic potential of human adipose-derived stem cells. |
| Q37290925 | Dioxinodehydroeckol Enhances the Differentiation of Osteoblasts by Regulating the Expression of Phospho-Smad1/5/8. |
| Q38112122 | Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer |
| Q35159388 | Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities |
| Q39670303 | Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells. |
| Q36390242 | Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro |
| Q90230389 | Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic Proteins |
| Q43183956 | Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes |
| Q34347325 | Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells |
| Q37699828 | Effects of 6-Hydroxyflavone on Osteoblast Differentiation in MC3T3-E1 Cells. |
| Q39346223 | Effects of IL-1 receptor-associated kinase-4 gene silencing on human osteoblast-like cells |
| Q94545648 | Effects of ginsenosides on bone remodelling for novel drug applications: a review |
| Q33850748 | Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanism |
| Q38207147 | Emerging therapeutic targets for osteoporosis treatment |
| Q38544771 | Enamel matrix proteins exhibit growth factor activity: A review of evidence at the cellular and molecular levels |
| Q42511847 | Enhanced osteogenesis by collagen-binding peptide from bone sialoprotein in vitro and in vivo |
| Q47679529 | Estradiol‑enhanced osteogenesis of rat bone marrow stromal cells is associated with the JNK pathway |
| Q42262240 | FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts |
| Q38541335 | Focus on the p38 MAPK signaling pathway in bone development and maintenance |
| Q36532502 | Function of BMPs and BMP antagonists in adult bone |
| Q35780863 | GDF-5 can act as a context-dependent BMP-2 antagonist |
| Q34078767 | Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts |
| Q37361864 | Graphene/single-walled carbon nanotube hybrids promoting osteogenic differentiation of mesenchymal stem cells by activating p38 signaling pathway |
| Q37732564 | Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells. |
| Q35036192 | Heterodimeric BMP-2/7 antagonizes the inhibition of all-trans retinoic acid and promotes the osteoblastogenesis |
| Q45770808 | High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway |
| Q38754192 | IGFBP5 enhances osteogenic differentiation potential of periodontal ligament stem cells and Wharton's jelly umbilical cord stem cells, via the JNK and MEK/Erk signalling pathways |
| Q50591956 | Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner. |
| Q40409155 | Immature osteoblastic MG63 cells possess two calcitonin gene-related peptide receptor subtypes that respond differently to [Cys(Acm)(2,7)] calcitonin gene-related peptide and CGRP(8-37). |
| Q52645690 | In vitro evaluation of the potential therapeutic role of Dendropanax morbifera extract in ameliorating osteoporosis and resultant bone impairment using MC3T3-E1 cells. |
| Q34386000 | Induction of interleukin-6 expression by bone morphogenetic protein-6 in macrophages requires both SMAD and p38 signaling pathways |
| Q41867094 | Inhibition of CK2 binding to BMPRIa induces C2C12 differentiation into osteoblasts and adipocytes. |
| Q36503171 | Inhibitory effect of bone morphogenetic protein-2 on the proliferation of giant cell tumor of bone stromal cells in vitro |
| Q38176443 | Initiation and early control of tissue regeneration - bone healing as a model system for tissue regeneration |
| Q50985415 | Interactions of total bone marrow cells with increasing quantities of macroporous calcium phosphate ceramic granules. |
| Q46407092 | Involvement of JNK in the embryonic development and organogenesis in zebrafish |
| Q54228291 | JNK MAPK is involved in BMP-2-induced odontoblastic differentiation of human dental pulp cells. |
| Q55031815 | LPS-stimulated inflammation inhibits BMP-9-induced osteoblastic differentiation through crosstalk between BMP/MAPK and Smad signaling. |
| Q38990158 | Lactoferrin stimulates osteoblast differentiation through PKA and p38 pathways independent of lactoferrin's receptor LRP1. |
| Q35006264 | M-Ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation |
| Q40248368 | MAPK signaling has stage-dependent osteogenic effects on human adipose-derived stem cells in vitro |
| Q64953317 | Mechanism of CK2.3, a Novel Mimetic Peptide of Bone Morphogenetic Protein Receptor Type IA, Mediated Osteogenesis. |
| Q41822489 | Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program |
| Q38157926 | Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. |
| Q47130932 | Molecular signaling mechanisms behind polyphenol-induced bone anabolism |
| Q42815985 | Na-doped β-tricalcium phosphate: physico-chemical and in vitro biological properties. |
| Q47156422 | Negative pressure wound therapy promotes muscle-derived stem cell osteogenic differentiation through MAPK pathway. |
| Q28510813 | Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity |
| Q36628270 | Networks and hubs for the transcriptional control of osteoblastogenesis. |
| Q35023903 | New insights in osteogenic differentiation revealed by mass spectrometric assessment of phosphorylated substrates in murine skin mesenchymal cells |
| Q39570977 | Noncanonical BMP signaling regulates cyclooxygenase-2 transcription. |
| Q24338390 | Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK |
| Q34323226 | O45-regulation of osteoblast differentiation and ECM remodeling by Bmp2/4 in vitro |
| Q53479869 | Odontogenic stimulation of human dental pulp cells with bioactive nanocomposite fiber. |
| Q37726092 | Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation |
| Q42814713 | Osteoblastic cell behavior on nanostructured metal implants. |
| Q87634087 | Osteogenic differentiation of bone mesenchymal stem cells regulated by osteoblasts under EMF exposure in a co-culture system |
| Q64097643 | Osteogenic differentiation of skeletal muscle progenitor cells is activated by the DNA damage response |
| Q44528474 | Over-sulfated chondroitin sulfate derivatives induce osteogenic differentiation of hMSC independent of BMP-2 and TGF-β1 signalling |
| Q35111595 | Palate morphogenesis: current understanding and future directions |
| Q36026589 | Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway |
| Q42834807 | Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation |
| Q27016578 | Proteomics approaches for the studies of bone metabolism |
| Q35758878 | Quercetin promotes the osteogenic differentiation of rat mesenchymal stem cells via mitogen-activated protein kinase signaling |
| Q35849580 | Rap1A Regulates Osteoblastic Differentiation via the ERK and p38 Mediated Signaling |
| Q35388360 | Regulation of tenascin expression in bone |
| Q38440258 | Relaxin augments BMP-2-induced osteoblast differentiation and bone formation |
| Q34389577 | Retracted: P38 and ERK1/2 MAPKs Act in Opposition to Regulate BMP9-Induced Osteogenic Differentiation of Mesenchymal Progenitor Cells |
| Q42481083 | Role of c-Jun N-terminal kinase in the osteogenic and adipogenic differentiation of human adipose-derived mesenchymal stem cells. |
| Q51601398 | Runx2/Cbfa1 stimulates transdifferentiation of primary skeletal myoblasts into a mineralizing osteoblastic phenotype. |
| Q41461912 | SMAD versus non-SMAD signaling is determined by lateral mobility of bone morphogenetic protein (BMP) receptors |
| Q36676867 | Signaling Cascades Governing Cdc42-Mediated Chondrogenic Differentiation and Mensenchymal Condensation |
| Q36606452 | Signaling and transcriptional regulation in osteoblast commitment and differentiation |
| Q36082866 | Signaling networks that control the lineage commitment and differentiation of bone cells |
| Q39982164 | Specific inhibitor of MEK-mediated cross-talk between ERK and p38 MAPK during differentiation of human osteosarcoma cells |
| Q39308262 | TGF-β Family Signaling in Mesenchymal Differentiation |
| Q34375611 | Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro |
| Q36242266 | The BMP signaling and in vivo bone formation |
| Q35656448 | The Effect of Quercetin on the Osteogenesic Differentiation and Angiogenic Factor Expression of Bone Marrow-Derived Mesenchymal Stem Cells |
| Q46234566 | The mineralization inducing peptide derived from dentin sialophosphoprotein for bone regeneration |
| Q33875419 | The p38α MAPK function in osteoprecursors is required for bone formation and bone homeostasis in adult mice |
| Q51790755 | The p38α MAPK positively regulates osteoblast function and postnatal bone acquisition. |
| Q24321603 | The pro-form of BMP-2 interferes with BMP-2 signalling by competing with BMP-2 for IA receptor binding |
| Q38031830 | The role of bone morphogenetic proteins in ankylosing spondylitis. |
| Q38316849 | Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways |
| Q28513591 | Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation |
| Q37112666 | c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis |
| Q39411766 | c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104. |
| Q26747239 | p38 MAPK Signaling in Osteoblast Differentiation |
| Q39671916 | p38 regulates expression of osteoblast-specific genes by phosphorylation of osterix |
| Q46292562 | p38a MAPK is involved in BMP-2-induced odontoblastic differentiation of human dental pulp cells |
Search more.